BALA CYNWYD, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Cidara Therapeutics, Inc. (Nasdaq - CDTX)

Under the terms of the Merger Agreement, Cidara will be acquired by Merck (NYSE- MRK) for $221.50 per share in cash, for a total transaction value of approximately $9.2 billion. The investigation concerns whether the Cidara Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/cidara-therapeutics-inc-nasdaq-cdtx/.

Mersana Therapeutics, Inc. (Nasdaq - MRSN)

Under the terms of the agreement, Mersana will be acquired by Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN) for $25 per share in cash at closing plus one non-tradable CVR per share to receive certain potential milestone payments of up to an aggregate of $30.25 per CVR in cash, for total consideration of up to $55.25 per share in cash, representing a total equity value of approximately $129 million at closing and representing a total deal value of up to approximately $285 million. The investigation concerns whether the Mersana Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/mersana-therapeutics-inc-nasdaq-mrsn/.

TreeHouse Foods Inc. (NYSE - THS)

Under the terms of the agreement, Tree House Foods will be acquired by Industrial F&B Investments III Inc. ("Investindustrial") for $22.50 per share in cash for each share of common stock owned at closing, and one non-transferable Contingent Value Right ("CVR") per common share in a transaction with a total Enterprise Value of $2.9 billion. The investigation concerns whether the TreeHouse Foods Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/treehouse-foods-inc-nyse-ths/.

Gulf Island Inc. (Nasdaq - GIFI)

Under the terms of the Merger Agreement, Gulf Island will be acquired by IES Holdings, Inc. ("IES") (Nasdaq - IESC) for $12.00 per share in cash for each share of common stock owned at closing, an aggregate equity value of approximately $192 million. The investigation concerns whether the Gulf Island Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/gulf-island-inc-nasdaq-gifi/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

COMTEX_470252210/2010/2025-11-14T10:41:50

BALA CYNWYD, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Cidara Therapeutics, Inc. (Nasdaq - CDTX)

Under the terms of the Merger Agreement, Cidara will be acquired by Merck (NYSE- MRK) for $221.50 per share in cash, for a total transaction value of approximately $9.2 billion. The investigation concerns whether the Cidara Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/cidara-therapeutics-inc-nasdaq-cdtx/.

Mersana Therapeutics, Inc. (Nasdaq - MRSN)

Under the terms of the agreement, Mersana will be acquired by Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN) for $25 per share in cash at closing plus one non-tradable CVR per share to receive certain potential milestone payments of up to an aggregate of $30.25 per CVR in cash, for total consideration of up to $55.25 per share in cash, representing a total equity value of approximately $129 million at closing and representing a total deal value of up to approximately $285 million. The investigation concerns whether the Mersana Therapeutics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/mersana-therapeutics-inc-nasdaq-mrsn/.

TreeHouse Foods Inc. (NYSE - THS)

Under the terms of the agreement, Tree House Foods will be acquired by Industrial F&B Investments III Inc. ("Investindustrial") for $22.50 per share in cash for each share of common stock owned at closing, and one non-transferable Contingent Value Right ("CVR") per common share in a transaction with a total Enterprise Value of $2.9 billion. The investigation concerns whether the TreeHouse Foods Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/treehouse-foods-inc-nyse-ths/.

Gulf Island Inc. (Nasdaq - GIFI)

Under the terms of the Merger Agreement, Gulf Island will be acquired by IES Holdings, Inc. ("IES") (Nasdaq - IESC) for $12.00 per share in cash for each share of common stock owned at closing, an aggregate equity value of approximately $192 million. The investigation concerns whether the Gulf Island Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/gulf-island-inc-nasdaq-gifi/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

COMTEX_470252210/2010/2025-11-14T10:41:50